期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

新辅助化疗在非小细胞肺癌治疗中的现状 被引量：1

在线阅读 下载PDF
导出
作者 张彬彬 杨桦 王思愚
机构地区 中山大学肿瘤医院
出处 《中国肺癌杂志》 CAS 2007年第5期443-447,共5页 Chinese Journal of Lung Cancer
基金 广东省科技厅科技项目(2005B3030102)资助
关键词 非小细胞肺癌 新辅助化疗 手术治疗 手术后辅助化疗 NSCLC 术前诱导化疗
分类号 R734.2 [医药卫生—肿瘤]
  • 相关文献

参考文献31

  • 1吴一龙.非小细胞肺癌的多学科综合治疗策略//吴一龙主编.肺癌多学科综合治疗的理论与实践.北京:人民卫生出版社,2000:178-229
  • 2Felip E, Vilar E. The expanding role of systemic treatment in non-small cell lung cancer neo-adjuvant therapy. Ann Oncol, 2006,17(Suppl 10) : x108-x112.
  • 3Rosell R, Gomez-Codina J, Camps C, et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med, 1994, 330 (3) : 153-158.
  • 4Rosell R, Gomez-Codina J, Camps C, et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer.N Engl J Med,1994,330(3) : 206-207
  • 5Rosell R, Gomez-Codina J, Camps C, et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer.N Engl J Med,1994, 330(24) : 1756;author reply 1757.
  • 6Rosell R, Gomez-Codina J, Camps C, et al. Preresectional chemotherapy in stage ⅢA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial. Lung Cancer, 1999, 26 (1) : 7-14.
  • 7Rosell R, Gomez-Codina J, Camps C, et al. Preresectional chemotherapy in stage ⅢA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial.Lung Cancer,2000,28(3) :247-251.
  • 8Roth JA, Fossella F, Komaki R, et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage ⅢA non-small-cell lung cancer. J Natl Can-cer Inst, 1994,86 (9) : 673-680.
  • 9Roth JA, Fossella F, Komaki R, et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage ⅢA non-small-cell lung cancer.J Natl Cancer Inst,1994,86(9) : 650-651.
  • 10Roth JA, Atkinson EN, Fossella F, et al. Long-term follow-up of patients enrolled in a randomized trial comparing perioperarive chemotherapy and surgery with surgery alone in resectable stage ⅢA non- small-cell lung cancer. Lung Cancer,1998,21(1) : 1-6.

二级参考文献37

  • 1Novoa N,Varela G,Jimenez MF.Morbidity after surgery for non-small cell lung carcinoma is not related to neoadjuvant chemotherapy.Eur J Cardiothorac Surg,2001,20:700-704.
  • 2Jocelyne M,Robert JG,Amir A,et al.Morbidity and mortality after neoadjuvant therapy for lung cancer:the risks of right pneumonectomy.Ann Thorac Surg,2001,72:1149-1154.
  • 3Christophe D,Pascal T,Xavier T,et al.Postoperative complications in relation with induction therapy for lung cancer.Eur J Cardiothorac Surg,2001,20:385-390.
  • 4Luca V,Luca L,Claudia G,et al.Results of induction chemotherapy followed by surgical resection in patients with stage ⅢA(N2) non-small cell lung cancer:the importance of the nodal down-staging after chemotherapy.Eur J Cardiothorac Surg,2001,20:1106-1112.
  • 5[1]Goss G, Paszat L, Newman TE, et al. Use of preoperative chemotherapy with or without postoperative radiotherapy in technically respectable stage Ⅲ non-small cell lung cancer [J]. Cancer Prev Control, 1998, 2(1):32～39
  • 6[2]Boer RH, Smith IE, Pastorino U, et al. Preoperative chemotherapy in early stage resectable non-small cell lung cancer: a randomized feasibility study justifying a multicenter phase Ⅲ trial [J]. Br J Cancer, 1999, 79(9):1514～1518
  • 7[4]Ukena D. Chemotherapy in stage Ⅰ + Ⅱ non-small cell lung cancer[J]. Lung Cancer, 2001, 33(1):25～28
  • 8[5]Murren JR, Buzaid AC, Hait WN, et al. Critical analysis of neoadjuvant therapy for stage Ⅲ a non-small cell lung cancer[J].Am Rev Resp Dis, 1991, 143(4): 889～894
  • 9[6]Tsuchiya Y, Onda M, Sasajima K, et al. Effect of preoperative chemotherapy on metastatic lymph nodes in esophageal squamous cell carcinoma[J]. Dis Esophagus, 2002, 15(3): 226～231
  • 10[7]Noda H, Kakeji Y, Kusumoto T, et al. Effectiveness of preoperative chemotherapy for far advanced gastric cancer [J]. Hepatogastroenterology, 2002, 49(44):379～382

共引文献148

同被引文献10

  • 1许燕云,刘标,唐慰萍,吴艳霞.散发性乳腺癌中BRCA1和cyclinB1的表达[J].临床与实验病理学杂志,2004,20(3):273-276. 被引量：12
  • 2WALKER S.Updates in non-small cell lung cancer[J].Clini-cal Journal of Oncology Nuring,2008,12(4):587-596.
  • 3ROSELL R,COBO M,ISLA D,et al.Applications of ge-nomics in NSCLC[J].Lung Cancer,2005,50(Suppl 2):S33-S40.
  • 4STEWART D J.Mechanism of resistance to cisplatin and car-boplatin[J].Crit Rev Oncol Hematol,2007,63(1):12-31.
  • 5SIMON G R,ISMAIL-KHAN R,BEPLER G.Nuclear exci-sion repair-based personalized therapy for non-small cell lungcancer:From hypothesis to reality[J].The International Jour-nal of Biochemistry&Cell Biology,2007,39(7/8):1318-1328.
  • 6TING N S,LEE W H.The DNA double-strand break re-sponse pathway:becoming more BRCAish than ever[J].DNARepair,2004,3(8/9):935-944.
  • 7FUJII T,TOYOOKA S,ICHIMURA K,et al.ERCC1pro-tein expression predicts the response of cisplatin-based neoad-juvant chemotherapy in non-small-cell lung cancer[J].LungCancer,2008,59(3):377-384.
  • 8TARON M,ROSELL R,FELIP E,et al.BRCA1mRNA ex-pression levels as an indicator of chemoresistance in lungcan-cer[J].Human Molecular Genetics,2004,13(20):2443-2449.
  • 9唐琳,梁军,李玉军.上皮性卵巢癌ERCC1表达与顺铂化疗耐药的关系[J].齐鲁医学杂志,2009,24(5):388-390. 被引量：6
  • 10周晓彬.医用统计学软件PPMS 1.5在医学科学研究中的应用价值[J].青岛大学医学院学报,2011,47(6):504-506. 被引量：101

引证文献1

二级引证文献9

中国肺癌杂志
2007年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部